Cited by 249Traumatic Brain Injury and Neurovascular DisturbancesTraumatic Brain Injury ResearchEthics in Clinical Research

Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials

Open access
Stein, Donald G.·2015·Brain Injury

Abstract

BACKGROUND: Despite positive preclinical studies and two positive Phase II clinical trials, two large Phase III clinical trials of progesterone treatment of acute traumatic brain injury (TBI) recently ended with negative results, so a 100% failure rate continues to plague the field of TBI trials. METHODS: This paper reviews and analyses the trial structures and outcomes and discusses the implications of these failures for future drug and clinical trial development. Persistently negative trial outcomes have led to disinvestment in new drug research by companies and policy-makers and disappointment for patients and their families, failures which represent a major public health concern. The problem is not limited to TBI. Failure rates are high for trials in stroke, sepsis, cardiology, cancer and orthopaedics, among others. RESULTS: This paper discusses some of the reasons why the Phase III trials have failed. These reasons may include faulty extrapolation from pre-clinical data in designing clinical trials and the use of subjective outcome measures that accurately reflect neither the nature of the deficits nor long-term quantitative recovery. CONCLUSIONS: Better definitions of injury and healing and better outcome measures are essential to change the embrace of failure that has dominated the field for over 30 years. This review offers suggestions to improve the situation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/02699052.2015.1065344

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Goodman SN, Gerson J, Mechanistic evidence in evidence-based medicine: A conceptual framework. Rockville, MD: Research White Paper Agency for Healthcare Research and Quality; 2013. Report No.: 13-EHC042-EF 24027800
  2. He W, Pinero J, Kuznetsova OM, editors. Practical considerations for adpative trial design and implementation. Statistics for biology and health. New York: Springer; 2014

Cited by

Sorted by citations

Authors
Stein, D. G.
Affiliations
Emory University (US)
Corresponding author
Stein, Donald G.
Venue
Brain Injury
Published
2015-08-14
Volume
29
Issue
11
Pages
1259-1272
ISSN
  • 0269-9052 (ISSN-L)
  • 1362-301X
OpenAlex
W1757695926
Cited by
249
References
102
Citations by year
2026: 17 · 2025: 16 · 2024: 19 · 2023: 26 · 2022: 14 · 2021: 20 · 2020: 25 · 2019: 25 · 2018: 30 · 2017: 24 · 2016: 27 · 2015: 5
FWCI
3.77
Type
journal article
Language
en
Open access
Locations
  • Brain Injury (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
Keywords
traumatic brain injury, progesterone, clinical trial failure, drug development, outcome measures, preclinical to clinical translation, stroke, sepsis
MeSH terms
Brain Injuries, Humans, Progestins, Progesterone, Treatment Outcome, Outcome Assessment, Health Care, Treatment Failure, Clinical Trials, Phase III as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review